We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Bank Irel13.375 | LSE:BOI | London | Bond |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 190.50 | 186.00 | 195.00 | 0 | 00:00:00 |
Hot Features
Premium
RNS Number:5798M
Biotrace International PLC
23 November 2006
For Immediate Release 23 November 2006
BIOTRACE INTERNATIONAL PLC
Holdings in Company
Biotrace International Plc, a leading manufacturer of industrial microbiology
products was informed yesterday that as at close of business on 20 November
2006, The Goldman Sachs Group Inc. ("GS Inc"), was interested, by attribution
only, in a total of 2,210,000 Ordinary 10p shares of the Group. The interest in
2,210,000 ordinary shares arose from a beneficial interest held by Goldman Sachs
International, a wholly-owned indirect subsidiary of GS Inc.
This notification relates to issued ordinary shares in the capital of the Group
and is given in fulfilment of the obligations imposed by sections 198-203 of the
Companies Act 1985.
- ENDS -
For further information, please contact:
Biotrace International Plc Tel: 01656 641400
Peter Morgan, Finance Director
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLILFFILSLVFIR
1 Year Bank Irel13.375 Chart |
1 Month Bank Irel13.375 Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
